High materiality8/10
TriSalus Life Sciences, Inc. (TLSI) PT Raised to $12 at H.C. Wainwright
Why it may matterVerify against the original reporting
Very bullish setup based on upside to target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Very bullish setup based on upside to target.
What happened, with direct paths to the underlying reporting
TLSI target update: target $12; current price $4.93; source Guggenheim.
Target: $12
Posted price: $4.93
Analyst firm: Guggenheim
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.